These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30531139)

  • 81. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
    J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
    Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
    Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
    [TBL] [Abstract][Full Text] [Related]  

  • 83. To and TAFRO - a cryptic cause of acute renal failure: a case report.
    Shah N; Davidson T; Cheung C; Keung K
    BMC Nephrol; 2022 Jan; 23(1):19. PubMed ID: 34991522
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CT findings in 11 patients with TAFRO syndrome: a variant of multicentric Castleman's disease.
    Kiguchi T; Sato C; Takai K; Nakai Y; Kaneko Y; Matsuki M
    Clin Radiol; 2017 Oct; 72(10):905.e1-905.e5. PubMed ID: 28629605
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
    Nishioka H; Takegawa H; Kamei H
    J Infect Chemother; 2018 Feb; 24(2):138-141. PubMed ID: 29021093
    [TBL] [Abstract][Full Text] [Related]  

  • 87. ANCA negative pulmonary renal syndrome with pathologic findings of thrombotic microangiopathy.
    Abdallah E; Al-Helal B; Al-Rashidi A; Asad R
    Arab J Nephrol Transplant; 2013 Jan; 6(1):31-5. PubMed ID: 23282231
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome].
    Masaki Y; Kawabata H; Takai K; Tsukamoto N; Fujimoto S; Ishigaki Y; Kurose N; Kojima M; Nakamura S; Kinoshita T; Aoki S;
    Rinsho Ketsueki; 2016; 57(10):2029-2037. PubMed ID: 27795511
    [TBL] [Abstract][Full Text] [Related]  

  • 89. TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report.
    Zhou B; Tang C; Chen G; Jiang T; Shi X; Wang F
    Hematol Oncol; 2023 Apr; 41(2):285-290. PubMed ID: 34997628
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid.
    Takeuchi N; Arai T; Kitaichi M; Inoue Y
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24072826
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report.
    Miyazaki S; Ikeda T; Ito G; Inoue M; Nara K; Nishinaga Y; Hasegawa Y
    J Med Case Rep; 2017 Dec; 11(1):356. PubMed ID: 29273073
    [TBL] [Abstract][Full Text] [Related]  

  • 92. TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.
    Louis C; Vijgen S; Samii K; Chalandon Y; Terriou L; Launay D; Fajgenbaum DC; Seebach JD; Muller YD
    Front Med (Lausanne); 2017; 4():149. PubMed ID: 29018798
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mixed-type multicentric Castleman's disease developing during a 17-year follow-up of sarcoidosis.
    Awano N; Inomata M; Kondoh K; Satake K; Kamiya H; Moriya A; Ando T; Kumasaka T; Takemura T; Takeuchi K; Ikushima S
    Intern Med; 2012; 51(21):3061-6. PubMed ID: 23124151
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Fatal Case of Thrombotic Microangiopathy Without Schistocytosis and Absent Biochemical Markers of Hemolysis.
    Saha BK; Saha A; Chong W; Beegle S
    Am J Med Sci; 2020 May; 359(5):296-302. PubMed ID: 32265009
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Acute renal failure due to thrombotic microangiopathy associated with Castleman's disease].
    López Montes A; Andrés Mompeán E; Martínez Villaescusa M; Llamas Fuente F; García-Mauriño Guelbenzu ML
    An Med Interna; 2007 Dec; 24(12):591-4. PubMed ID: 18278998
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 97. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
    Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 99. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Thrombotic microangiopathy due to malignant hypertension complicated with late-onset bleeding after renal biopsy].
    Ameda S; Kuroda H; Yamada M; Sato K; Miura S; Sakano H; Shibata T; Uemura N; Abe T; Fujii S; Maeda M; Fujita M; Kobune M; Kato J
    Rinsho Ketsueki; 2017; 58(6):637-642. PubMed ID: 28679995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.